WFRD:NASDAQWeatherford International plc Analysis
Data as of 2026-05-10 - not real-time
$102.32
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading above both its short‑term and intermediate moving averages, signaling a bullish alignment, while the RSI hovers around the midpoint, indicating neutral momentum. The MACD histogram has turned negative, suggesting short‑term downside pressure, and volume has been on a decreasing trend, which may limit upward thrust. Price sits comfortably above the recent support zone but remains below the historical resistance ceiling, providing a cushion against immediate pullbacks. The equity exhibits a beta above one and a 30‑day volatility approaching 40%, reflecting heightened sensitivity to market swings, and the Fear & Greed Index currently reads “Extreme Greed,” underscoring bullish sentiment.
Fundamental backdrop: Recent earnings disclosed a modest revenue contraction year‑over‑year, yet margins stay respectable with operating profitability above 10% and a solid free‑cash‑flow generation. The company completed a sizable share‑repurchase program, declared a cash dividend with a low payout ratio, and secured new contracts that should bolster order flow. A strategic redomiciling to the United States aims to simplify the corporate structure and may improve access to capital. Analyst consensus remains “Buy” with a median price target implying roughly a 15% upside, while the DCF‑derived fair value sits below the current market level, hinting at potential overvaluation in the short run.
Fundamental backdrop: Recent earnings disclosed a modest revenue contraction year‑over‑year, yet margins stay respectable with operating profitability above 10% and a solid free‑cash‑flow generation. The company completed a sizable share‑repurchase program, declared a cash dividend with a low payout ratio, and secured new contracts that should bolster order flow. A strategic redomiciling to the United States aims to simplify the corporate structure and may improve access to capital. Analyst consensus remains “Buy” with a median price target implying roughly a 15% upside, while the DCF‑derived fair value sits below the current market level, hinting at potential overvaluation in the short run.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term averages but MACD turning bearish
- Decreasing volume limiting momentum
- Support level providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus buy with upside potential
- Strong cash flow and low dividend payout supporting sustainability
- New contract wins and share‑repurchase enhancing earnings per share
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Cyclical exposure to oil & gas demand
- Redomiciling and debt profile improvement over time
- Stable dividend and cash generation for shareholder returns
Key Metrics & Analysis
Financial Health
Revenue Growth-3.40%
Profit Margin9.49%
P/E Ratio16.0
ROE30.78%
ROA8.74%
Debt/Equity92.67
P/B Ratio4.2
Op. Cash Flow$670.0M
Free Cash Flow$447.8M
Industry P/E20.3
Technical Analysis
TrendBullish
RSI47.8
Support$96.35
Resistance$112.31
MA 20$104.73
MA 50$98.26
MA 200$80.46
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Fair Value$74.27
Target Price$117.92
Upside/Downside15.24%
GradeOvervalued
TypeBlend
Dividend Yield1.08%
Risk Assessment
Beta1.18
Volatility38.76%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.